1. Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study. Issue 5 (May 2017) Authors: DeJesus, Edwin; Ramgopal, Moti; Crofoot, Gordon; Ruane, Peter; LaMarca, Anthony; Mills, Anthony; Martorell, Claudia T; de Wet, Joseph; Stellbrink, Hans-Jürgen; Molina, Jean-Michel; Post, Frank A; Valero, Ignacio Pérez; Porter, Danielle; Liu, YaPei; Cheng, Andrew; Quirk, Erin; SenGupta, Devi; Cao,... Journal: Lancet Issue: Volume 4:Issue 5(2017) Page Start: e205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗